Keywords: synergen, cuts, workforce, following, news, potential, treatment

Synergen Cuts Workforce by 60%

Article | 08 August 1994

Print This

Following the news that Synergen's potential treatment for severe sepsis Antril (anakinra) had shown lack of efficacy in Phase III ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in